Marc E. Lippman, Director at SEATTLE GENETICS INC /WA (SGEN), sold 1,000 shares at $152.03 ($152K) on 2020-05-04, disclosed to the SEC on 2020-05-06.
Seasonal sale ($152k) by Director — this insider has traded SGEN in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| SGEN | SELL | 2018-08-02 | $512K | — | Filing → |
| SGEN | SELL | 2017-11-17 | $174K | — | Filing → |
| SGEN | SELL | 2016-11-09 | $58K | — | Filing → |